Amgen reported $464M in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 766M 2787M
Acceleron Pharma XLRN:US $ -63.52M 0.05M
Agios Pharmaceuticals AGIO:US $ -86.22M 1960.54M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
ALKERMES ALKS:US $ 2.36M 24.78M
Amgen AMGN:US $ 464M 1182M
Astrazeneca AZN:US $ 550M 1011M
Biogen BIIB:US $ 448.5M 38.3M
Biomarin Pharmaceutical BMRN:US $ 12.94M 4.43M
Bluebird Bio BLUE:US $ -241.7M 35.89M
Bristol Myers Squibb BMY:US $ 1055M 966M
Coherus Biosciences CHRS:US $ -29.9M 143.05M
Dicerna Pharmaceuticals DRNA:US $ -40.82M 10.85M
Eli Lilly And LLY:US $ 1390.2M 34.9M
Exelixis EXEL:US $ 96.09M 94.49M
Genmab GEN:DC DK 306M 790M
Gilead Sciences GILD:US $ 1522M 207M
Glaxosmithkline GSK:US $ 1395M 322M
GlaxoSmithKline GSK:LN 1395M 322M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
IONIS PHARMACEUT IONS:US $ -80.88M 8.99M
Johnson & Johnson JNJ:US $ 6278M 81M
Merk MRK:US $ 1545M 1634M
Mirati Therapeutics MRTX:US $ -166.43M 30.75M
Moderna Inc MRNA:US 2.78B 1.56B
Neurocrine Biosciences NBIX:US $ 42.3M 10.2M
Novartis NVS:US $ 2896M 837M
Novartis NOVN:VX SF 2896M 837M
Pfizer PFE:US $ 5564M 686M
Ptc Therapeutics PTCT:US $ -118.37M 10.27M
Puma Biotechnology PBYI:US $ -5.11M 21.63M
Regeneron Pharmaceuticals REGN:US $ 3098.9M 1983.7M
Sarepta Therapeutics SRPT:US $ -81.4M 85.84M
Seattle Genetics SGEN:US $ -84.58M 36.84M
Takeda 4502:JP Y 200377M 3279M
Teva Pharmaceutical TEVA:IT 207M 129M
Ultragenyx Pharmaceutical RARE:US $ -122.43M 13.71M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M
YTE INCY:US $ 149.46M 95.92M